Advanced Interventions Service
Specialist Services for OCD and depression

The Dundee Advanced Interventions Service is a specialist service providing: intensive treatment for obsessive-compulsive disorder (OCD); specialist assessment and treatment for depression and OCD; and neurosurgical treatment for mental disorder.

Specialist mental health services
For the people of Scotland

We are a National Specialist Service, which means that we are one of over 80 national services in Scotland, receiving funding directly from the National Services Division (NSD) of NHS Scotland. Referral, assessment, and treatment are cost-free to NHS Boards in Scotland.

We have considerable experience in the fields of neuromodulation, and expert-led psychopharmacology, along with being the only multi-disciplinary neurosurgical service in the UK for psychiatric disorders.

Services available

We offer specialist treatment for OCD and depression. We also provide expert diagnostic assessments for related conditions, and can offer advice on treatment. Select an option to read more...

Obsessive-Compulsive Disorder

We offer a range of interventions for OCD, including:

  1. Specialist assessment of obsessive-compulsive and related disorders (OCARD), including complex diagnostic assessment of OCD in combination with other disorders such as autism spectrum disorder (ASD).
  2. Supporting local teams in Scotland to deliver exposure-and-response prevention (ERP).
  3. Intensive (including inpatient) treatment.
  4. Online treatment.
  5. Psychiatric neurosurgery (anterior cingulotomy and anterior capsulotomy).
Picture of handwashing


We have longstanding expertise in assessing and treating mood disorders, including depression. We can provide:

  1. Confirmation of diagnosis.
  2. Advice on expert psychopharmacology.
  3. Advice on psychological treatment.
  4. Guidance on ECT and neuromodulation.
  5. Neurosurgical pathways for treatment-refractory depression.
Picture of depressed person

Mood disorders

We are able to assess complex and treatment-refractory bipolar disorder(s) and offer advice on treatment.

For individuals with chronic and treatment-refractory bipolar depression, we can provide guidance on the suitability of neurosurgical treatments.

Picture of clinical interview

COVID-19: last updated on 6 May 2022

Whilst NHS services continue to be affected by COVID-19, most services are slowly finding the 'new normal'. Whilst we will often offer to provide assessment remotely in most instances, we are happy to see people face-to-face if there are good reasons to, or that is their preference. In some cases, we might use a hybrid approach.

Our intensive treatment programmes have largely returned to pre-pandemic approaches, and we will discuss the best way of delivering treatment with each person. We can treat people in hospital, at home, or as an outpatient. Usually, in combinations. We are still providing some treatment remotely going forward.

We continue to receive referrals as usual. If you have any questions about a possible referral, or would like to discuss something, please get in touch.

We have adopted a 'digital by default' approach which means we will still aim to assess the majority of people via videoconference (Zoom, Skype, etc.). This means that people can be assessed in the comfort of their own homes and they do not have to travel. We are confident that this allows a comprehensive review of the patient's condition so that treatment recommendations can be made.

Where people are unable to be assessed remotely, they have a strong preference for being seen face-to-face, or if it makes sense to complete assessments face-to-face, we will arrange this. We will still be following all relevant COVID-19 restrictions and all staff in the department have been vaccinated against COVID-19.

Over the last year we have continued to provide online intensive treatment to those individuals where this approach may be helpful. We are also providing treatment in inpatient settings, homes, and as outpatients. The type of treatment we offer is agreed on a case-by-case basis.

People can travel to London for surgery. We are in close contact with neurosurgical colleagues in London who perform the surgery so that we can make sure that arrangements suit each person, whilst keeping risks as low as possible.

We are now able to arrange neuropsychological assessment, MRI scanning, and review in Dundee but we will discuss this with the individual because some people might prefer not to travel.

Other resources

Please browse our resources for information on how to treat OCD and depression. We also publish our annual reports covering activity and outcomes.

Want to make a referral?

Need to know more?

If you would like further information on referral, or are a clinician who wishes to make a referral, please click on the button to view our referral FAQ.

Latest blog entries

We try to provide updated information on treatment, and comment on issues that relate to OCD and depression.

Image of coffee beans

Novel treatments for OCD: caffeine

Most of us will consume caffeine in some form, but what if it could reduce symptoms of OCD? A recent study (Naftalovich et al, 2020) explored whether caffeine could help inhibition - which includes the ability to suppress or change intrusive...

Read More
Image of mushrooms

Novel treatments for depression: psilocybin

In this blog I discuss a recent publication (Davis et al, 2020) which looked at a novel treatment for depression: Psilocybin. I review the study, look at the outcomes, and consider what the implications might be for treatment.

Read More
Picture of clock

How long does someone with OCD have symptoms before getting help?

It is fairly well known that people with OCD have symptoms for a long time before seeking help, and wait longer before receiving effective treatment. In light of a new study from Brazil about the speed of development of OCD symptoms (Thompson et al,...

Read More
Picture of handwashing to represent OCD

The effects of COVID-19 pandemic on OCD symptoms

In this blog, we look at a recent paper (Nissen et al, 2020) exploring the effects of COVID-19 on OCD symptoms in two groups of young people: one was a clinical group; the other was a group identified via the Danish OCD Association.

Read More
Picture of tablets/ medication

Evidence review: N-acetylcysteine for OCD

In this blog, I review six randomised, controlled trials comparing N-Acetylcysteine (NAC) versus placebo for the treatment of OCD. NAC is a glutamate regulator and has good tolerability. Four trials tested it in adults, and two tested it in children.

Read More
Picture of videoconferencing

Delivering treatment for OCD during a pandemic: what have we learned in the AIS?

The pandemic has had a dramatic effect on the whole of the NHS, but it has also affected the availability of services for OCD. Not only that, but the nature of the pandemic will have had effects on many people with OCD; particularly those with...

Read More